Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
Ford, Hugo E R, Dr, Marshall, Andrea, PhD, Bridgewater, John A, PhD, Janowitz, Tobias, PhD, Coxon, Fareeda Y, MRCP, Wadsley, Jonathan, FRCR, Mansoor, Wasat, PhD, Fyfe, David, MD, Madhusudan, Srinivasan, FRCP, Middleton, Gary W, Prof, Swinson, Daniel, MD, Falk, Stephen, MD, Chau, Ian, MD, Cunningham, David, Prof, Kareclas, Paula, PhD, Cook, Natalie, PhD, Blazeby, Jane M, Prof, Dunn, Janet A, Prof
Published in The lancet oncology (2014)
Published in The lancet oncology (2014)
Get full text
Journal Article